Psychoeducation for Adult Siblings of ASD People (Autism Spectrum Disorder).

September 9, 2026 updated by: Charalampos Depastas, Hellenic Mediterranean University

The Effect of Psychoeducation on Adult Siblings of People With Autism Spectrum Disorder.

The purpose of this study was to evaluate the effectiveness of a novel psychoeducational program for adult siblings of autistic individuals, aiming to improve autism-related knowledge, well-being, resilience and sibling relationship outcomes, while also highlighting the need for tailored supportive interventions for this population.

The psychoeducational program will be implemented in adult siblings of people with ASD and its effectiveness will be assessed.

We expect that after the intervention, participants in the intervention group will demonstrate improvements in the study outcomes compared with participants in the control group, and that some of these improvements will be maintained at the three-month follow-up. We further expect that the participants' level of caregiving involvement with their autistic sibling will be associated with the effectiveness of the intervention. No risk is identified.

Study Overview

Detailed Description

Autism Spectrum Disorder (ASD) is a neurodevelopmental lifelong disorder of which prevalence has been significantly increased through the decades.

As a result, the rise in autism prevalence has been accompanied by a parallel increase in the number of individuals who have autistic siblings, a group estimated to number in the millions.

Although supportive interventions have demonstrated benefits for family members, existing research has primarily focused on autistic individuals and their parents. Consequently, evidence regarding interventions specifically designed for adult siblings remains limited.

The purpose of this study was to evaluate the effectiveness of a novel psychoeducational program for adult siblings of autistic individuals, aiming to improve autism-related knowledge, well-being, resilience and sibling relationship outcomes, while also highlighting the need for tailored supportive interventions for this population. The psychoeducational program aims to enhance understanding of autism, encourage emotional expression and a sense of belonging, improve family and sibling communication, and provide practical strategies for everyday challenges.

A parallel-group randomized controlled trial with assessments at baseline, post-intervention and three-month follow-up will be conducted among adult siblings of autistic individuals across Greece (voluntary participation). Participants will be randomly allocated (1:1) to the intervention or control group. The intervention comprise six free-of-charge online psychoeducational sessions and one follow-up session and will be delivered by two social workers certified in autism psychoeducation, whereas the control group will complete questionnaires only.

We expect that after the intervention, participants in the intervention group will demonstrate improvements in the study outcomes compared with participants in the control group, and that some of these improvements will be maintained at the three-month follow-up. We further expect that the participants' level of caregiving involvement with their autistic sibling will be associated with the effectiveness of the intervention. No risk is identified.

This study is part of a doctoral thesis in progress at the Hellenic Mediterranean University (HELMEPA), Department of Social Work.

The study is expected to start in April 2024 and to be completed about six months later.

Study Type

Interventional

Enrollment (Actual)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Crete
      • Heraklion, Crete, Greece, 82102
        • Hellenic Mediterranean University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria were: (i) age 18 or older, (ii) having one sibling with a clinical diagnosis of ASD, (iii) no self-reported neurodevelopmental diagnosis, (iv) no prior participation in a psychoeducational program for autism and v) able to understand and communicate in Greek.

Exclusion criteria were: (i) having more than one sibling diagnosed with ASD, and (ii) residing outside Greece.

Participants were also required to have access to the internet and a device capable of participating in the online audiovisual sessions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychoeducation Program Group

Participants are going to participate in the online psychoeducational program for ASD.

Number of participants: 44.

They will will be asked to complete the online questionnaires three times (pre-intervention, post-intervention and at the three-month follow-up).

6 psychoeducational sessions and one follow-up session for Autism Spectrum Disorder
No Intervention: Questionnaires Only Group

Concurrently with the intervention group, the control group will be asked to complete the online questionnaires three times (pre-intervention, post-intervention and three-month follow-up).

Number of participants: 44.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychoeducation effectiveness on the knowledge of ASD
Time Frame: 6 months
The evaluation of psychoeducational program effect on knowledge of ASD is going to be evaluated throw the "Participatory Autism Knowledge Scale" questionnaire (29-item scale) will be used. The original validation studies demonstrated satisfactory psychometric properties, showing good internal consistency. The standardization and adaptation of the questionnaire into Greek has not yet been published in a peer-reviewed journal.
6 months
Psychoeducation effectiveness on siblings relationship
Time Frame: 6 months
A newly developed research measure, designed specifically for this study to assess negative emotions and attitudes of adult siblings toward their autistic sibling. The questionnaire's name is "Adult Sibling Relationships and Autism Spectrum Questionnaire (ASRQ-AS) " - 31-item scale. The standardization and adaptation of the questionnaire into Greek has not yet been published in a peer-reviewed journal.
6 months
Psychoeducation effectiveness on resilience of siblings of ASD
Time Frame: 6 months
The Brief Resilience Scale (BRS) was developed to assess an individual's ability to recover from stress and adversity. It can also be used to examine factors and outcomes associated with resilience in both mental and physical health, identifying individuals who may benefit from supportive or therapeutic interventions. The internal consistency (Cronbach's α) of the BRS demonstrates good reliability as well as in Greek version.
6 months
Psychoeducation effectiveness on the well-being of siblings of ASD
Time Frame: 6 months
The evaluation of psychoeducational program effect on the well-being is going to be evaluated throw the questionnaire "PERMA-Profiler" (23-item scale). The scale has demonstrated adequate reliability and validity in assessing well-being - Cronbach's α values.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: CHARALAMPOS DEPASTAS, PhD stud., Hellenic Mediterranean University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2024

Primary Completion (Actual)

October 30, 2024

Study Completion (Actual)

October 30, 2024

Study Registration Dates

First Submitted

March 28, 2024

First Submitted That Met QC Criteria

April 7, 2024

First Posted (Actual)

April 11, 2024

Study Record Updates

Last Update Posted (Actual)

September 10, 2026

Last Update Submitted That Met QC Criteria

September 9, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

We will keep the anonymity of participants and there is no plan to share their data to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe